Discontinued — last reported Q2 '24
ResMed Sleep and Respiratory Care — Net revenue increased by 2.1% to $1.07B in Q2 2024 compared to the prior quarter. Year-over-year, this metric grew by 8.9%, from $983.48M to $1.07B. Over 3 years (FY 2021 to FY 2024), Sleep and Respiratory Care — Net revenue shows an upward trend with a 13.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth indicates successful market penetration, product adoption, or price increases; decline suggests market saturation or competitive pressure.
The total amount of money generated from the sale of sleep and respiratory care products and services, net of returns, a...
The primary growth metric for all public companies; peers report this as 'Segment Revenue'.
rmd_segment_sleep_and_respiratory_care_net_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $780.33M | $806.50M | $795.84M | $763.36M | $811.60M | $844.44M | $916.98M | $980.12M | $983.48M | $963.04M | $1.02B | $1.05B | $1.07B |
| QoQ Change | — | +3.4% | -1.3% | -4.1% | +6.3% | +4.0% | +8.6% | +6.9% | +0.3% | -2.1% | +5.7% | +3.1% | +2.1% |
| YoY Change | — | — | — | — | +4.0% | +4.7% | +15.2% | +28.4% | +21.2% | +14.0% | +11.0% | +7.0% | +8.9% |